Hybridoma Technology
Drug Products: Biologics, Biosimilars and Interchangeables
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 16, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
1Nature Biotechnology. Photo at top of page is Ted Love, CEO of Global Blood Therapeutics.
No abstract available in PubMed .
08:20Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
Published on: December 2, 2022
09:43Purification and Refolding to Amyloid Fibrils of His6-tagged Recombinant Shadoo Protein Expressed as Inclusion Bodies in E. coli
Published on: December 19, 2015